-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. Recently, Guangzhou Yipinhong Pharmaceutical Co., Ltd. (“Yipinhong Pharmaceutical”), a wholly-owned subsidiary of the company, received a letter from the US Food and Drug Administration (FDA) agreeing to the clinical trial of the innovative drug APH04935 tablets independently developed by the company's subsidiary.

Zhitongcaijing·10/08/2026 03:57:10
Listen to the news
Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. Recently, Guangzhou Yipinhong Pharmaceutical Co., Ltd. (“Yipinhong Pharmaceutical”), a wholly-owned subsidiary of the company, received a letter from the US Food and Drug Administration (FDA) agreeing to the clinical trial of the innovative drug APH04935 tablets independently developed by the company's subsidiary.